Population-based screening programmes for Chlamydia trachomatis [5]

Lancet

Volumn 349, Issue 9058, 1997, Pages 1070-1071

  Caul, E Owen ^a   Horner, Patrick J ^b   Leece, Jo ^b   Crowley, Tessa ^b   Paul, Ian ^b   Davey Smith, George ^b  

^a Public Health Laboratory   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; ENZYME IMMUNOASSAY; GENE AMPLIFICATION; HUMAN; LABORATORY TEST; LETTER; MALE; PRIORITY JOURNAL; SCREENING; URINALYSIS;

EID: 0030964799     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62293-3     Document Type: Article

References (5)

1. Caul EO, Paul ID, Milne JD, CrowleyT. Non-invasive sampling method for detecting Chlamydia trachomatis. Lancet 1989; ii: 1246-47.
2. Lee HH, Chernesky MA, Schachter J, et al. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet 1995; 345: 213-16.
3. Johnson AM, Grun L, Haines A. Controlling genital chlamydial infection. BMJ 1996; 313: 1160.
4. Hadgu A.The discrepancy in discrepant analysis. Lancet 1996; 348: 592-93.
5. Østergaard L, Møller JK, Andersen B, Olesen F. Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. BMJ 1996; 313: 1186-89.